African Journal of
Microbiology Research

  • Abbreviation: Afr. J. Microbiol. Res.
  • Language: English
  • ISSN: 1996-0808
  • DOI: 10.5897/AJMR
  • Start Year: 2007
  • Published Articles: 5233

Full Length Research Paper

Antifungal resistance and herbal sensitivity of oral Candida isolates from HIV-infected patients in a rural community in Western Uttar Pradesh, India

Rajeev Kumar Gautam*
  • Rajeev Kumar Gautam*
  • Department of Medicine, Arba Minch University, Arba Minch, Ethiopia
  • Google Scholar
Amar Prakash Garg
  • Amar Prakash Garg
  • Department of Microbiology, Chaudhary Charan Singh University, Meerut- 250005, Uttar Pradesh, India
  • Google Scholar


  •  Received: 10 December 2013
  •  Accepted: 24 March 2014
  •  Published: 16 April 2014

References

Agarry OO, Olaleye MT, Bello-Michael CO (2005). Comparative antimicrobial activities of Aloe veragel and leaf. Afr. J. Biotechnol. 4 (12):1413-1414.

View

 
Basu S, Gugnani, HC, Joshi S, Gupta N (2003). Distribution of Candida species in different clinical sources in Delhi, India and proteinase and phospholipase activity of Candida albicans isolates. Rev. Iberoam. Micol. 20(4):137-140.
Pubmed
 
Bharathi M, Rani AU (2011). Pathogenic fungal isolates in sputum of HIV positive patients. J. AIDS and HIV Res. 3:107-113.
 
Bokaeian M, Nakhaee A, Moodi B, Farhangi A, Akbarzadeh A (2010). Effects of garlic extract treatment in normal and streptozotocin diabetic rats infected with Candida albicans. In. J. Clin. Biochem. 25 (2):182-187.
Crossref
 
Brito GNB, Inocêncio, AC, Querido, SMR, Jorge, AOC, Koga-Ito, CY (2010). In vitro antifungal susceptibility of Candida spp. oral isolates from HIV-positive patients and control individuals. Braz. Oral. Res. 25(1):28-33.
Crossref
 
Carrillo-Mu-oz AJ, Tur C, Estivill D, Montsant L, Carceller A, Hernández-Molina JM (1997). Resistencia in vitro al fluconazol e itraconazol en aislamientos clínicos de Candida sp. y Cryptococcus neoformans. Rev. Iberoam. Micol. 14:50-54.
 
Chunchanur SK, Nadgir SD, Halesh LH, Patil BS, Kausar Y, Chandrasekhar MR (2009). Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients. In. J. Pathol. Microbiol. 52:501-504.
Crossref
 
Clinical and Laboratory Standard Institute (2008). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard- Third Edition M27-A3. National Committee for Clinical Laboratory Standards, Wayne, Pennsylvania, USA.
 
da Matta DA, de Almeida LP, Machado AM, Azevedo AC, Kusano EJU, Travassos NF (2007). Antifungal susceptibility of 1000 Candida bloodstream isolates to antifungal drugs: results of a multicenter study conducted in Sao Paulo, Brazil, 1995-2003. Diagn. Microbiol. Infect. Dis. 57:399-404.
Crossref
 
Doddanna SJ, Patel S, Sundarrao MA, Veerabhadrappa RS (2013). Antimicrobial activity of plant extracts on Candida albicans: An in vitro study. In. J. Dent. Res. 24(4):401-405
 
Ellepola AN, Samaranayake LP (2000). Antimycotic agents in oral candidiasis: An overview: Treatment of oral candidosis. Dent. Update. 27:165-170.
Pubmed
 
Espinel-Ingroff A, Brachiesi F, Hazen KC, Martinez-Suarez JV, Scalise G (1998). Standardization of antifungal susceptibility testing and clinical relevance. Med. Mycol. 36:68-78.
Pubmed
 
Gautam RK, Garg AP (2013a). Drug resistance and antifungal activity of garlic and neem extracts on Candida spp. isolates from HIV-infected patients. Int. J. Adv. Pharm. Res. 4(2):1426-1433.
 
Gautam RK, Garg AP (2013b). Evaluation of risk factors and prevalence of oral candidiasis in HIV-infected patients with and without oral lesions in Western Uttar Pradesh, India. J. Infec. Dis. Photon. 112:168-175.
 
Gautam RK, Garg AP (2013c). Microbiological and clinical assessment of Candida carriage in different clinical samples from HIV-infected and non infected patients. Sch. J. App. Med. Sc. 1(2):69-75.
 
George D, Bhat SS, Antony B (2009). Comparative evaluation of the antimicrobial efficacy of Aloe vera tooth gel and two popular commercial toothpastes: an in vitro study. Gen. Dent. 57(3):238-241
Pubmed
 
Gugnani HC, Becker K, Fegeler W, Basu S, Chattopadhya D, Baveja U (2003). Oropharyngeal carriage of Candida species in HIV-infected patients in India. Mycoses. 46:299-306.
Crossref
 
Jafari AA, Bafghi AF, Anvari MH, Zarrinfar H (2007). In vitro synergism effect of an aqueous garlic extracts against six commonly clinical isolated Candida species. Iranian J. Pub. Health. 36(1):1-2.
 
Jain PA, Kulkarni RD, Ajantha GS, Shubhada C (2011). A comparative evaluation of oral Candida carriage in HIV-infected individuals and HIV seronegative healthy individuals in north Karnataka. J. Biosci. Tech. 2:232-237.
 
Kaur J, Xavier R, Marimuthu, Leng KM, Rajasekaran A, Kathiresan S, Sreeramanan S (2010). Preliminary investigation on the antibacterial activity of mango (Mangifera indica L: Anacardiaceae) seed kernel. Asian Pacific. J. Trop. Med. 3(9):707-710.
 
Lai PK, Roy J (2004). Antimicrobial and chemopreventive properties of herbs and spices. Curr. Med. Chem. 11:1451-1460.
Crossref
 
Luque AG, Biasoli MS, Tosello ME, Binolfi A, Lupo S, Magaro HM (2008). Oral yeast carriage in HIV-infected and non-infected populations in Rosario, Argentina. Mycoses. 52:53-59.
Crossref
 
Mahmoud DA, Hassanein NM, Youssef KA, AbouZeid MA (2011). Antifungal activity of different neem leaf extracts and the nimonol against some important human pathogens. Braz. J. Microbiol. (2011) 42:1007-1016
Crossref
 
Mane A, Panchvalli S, Bembalkar S, Risbud A (2010). Species distribution and antifungal susceptibility of oral Candida colonizing or infecting HIV infected individuals. Letter to Editor, In. J. Med. Res. pp 1.
 
Mathema B, Cross E, Dun E, Park S, Bedell J, Slade B (2001). Prevalence of vaginal colonization by drug-resistant Candida species in college-age women with previous exposure to over-the-counter azole antifungals. Clin. Infect. Dis. 33:23-27.
Crossref
 
Merçon M, Tuboi SH, Batista SM, Telles SR, Grangeiro JR, Zajdenverg R (2009). Risk-based assessment does not distinguish between recent and chronic HIV-1 infection in Rio de Janeiro, Brazil. Braz. J. Infect. Dis. 13:272-275.
Crossref
 
Moura MDG, Grossman SMC, Fonseca LMS, Ramos-Jorge ML, Mesquita RA (2010). Risk factors for oral candidiasis in Brazilian HIV-infected adult patients. Braz. J. Oral. Sci. 9(4):470-474.
 
Moura MDG, Grossmann SMC, Fonseca LMS, Senna MIB, Mesquita RA (2006). Risk factors for oral hairy leukoplakia in HIV-infected adults of Brazil. J. Oral Pathol. Med. 35:321-326.
Crossref
 

Obasi NL, Egbuonu ACC, Ukoha PO, Ejikeme PM (2010). Comparative phytochemical and antimicrobial screening of some solvent extracts of Samanea saman pods. Afr. J. Pure and Appl. Chem. 4(9):206-212.

View

 
Padhye S, Rai S, Narula N, Dekate S (2013). Screening of antifungal activity of some essential oils and antifungals on clinical fungal isolates from diabetic patients. Res. J. Pharm. Biol. Chem. Sc. 4(2): 16-21.
 
Pfaller MA, Diekema DJ (2007). Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20:133-163.
Crossref
 
Raphael E (2012). Phytochemical constituents of some leaves extract of Aloe vera and Azadirachta indica plant species. Glob. Adv. Res. J. Env. Sc. Toxicol. 1(2):14-17.
 
Roopashree TS, Dang R, Rani SRH, Narendra C (2008). Antibacterial activity of anti-psoriatic herbs: Cassia tora, Momordica charantia and Calendula officinalis. Int. J. App. Res. Natur. Prod. 1(3):20-28.
 
Thiago ASA, Nelson LA, Elba LCA, Ulysses PA (2008). A new approach to study medicinal plants with tannins and flavanoids contents from the local knowledge. J. Ethnopharmacol. 120:72-80.
Crossref
 
Thompson GR 3rd, Patel PK, Kirkpatrick WR, Westbrook SD, Berg D, Erlandsen J (2010). Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 109(4):488-495.
Crossref
 
Vazquez JA, Peng G, Sobel JD, Steele-Moore L, Schuman P, Holloway W (2001). Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis. Clin. Infect. Dis. 33:1069-1075.
Crossref